New article published in Biomedical Optics Express: https://doi.org/10.1364/BOE.9.005946Kate Grieve, Elena Gofas-Salas, R. Daniel Ferguson, José Alain Sahel, Michel Paques, and Ethan A. Rossi, "In vivo near-infrared autofluorescence imaging of retinal pigment epithelial cells with 757 nm excitation," Biomed. Opt. Express 9, 5946-5961 (2018)


Tutorial video  by Céline Chaumette on clincal adaptive optics imaging available online (in French)


New article published in Progress in Retinal and Eye Research, "Adaptive optics ophthalmoscopy: Application to age-related macular degeneration and vascular diseases", M Paques, S Meimon, F Rossant, D Rosenbaum, S Mrejen, F Sennlaub, K Grieve


New article published in Applied Optics: "High loop rate adaptive optics flood illumination ophthalmoscope with structured illumination capability," Elena Gofas-Salas, Pedro Mecê, Cyril Petit, Jessica Jarosz, Laurent M. Mugnier, Aurélie Montmerle Bonnefois, Kate Grieve, José Sahel, Michel Paques, and Serge Meimon, Appl. Opt. 57, 5635-5642 (2018)


Thank you for your participation in our successful course in Adaptive Optics: Autumn Course on Adaptive Optics Imaging, October 8, 2018, Institut Langevin, Paris, France


Welcome to the website of the Paris Group! We are a team of ophthalmologists and physicists interested in high resolution imaging of the human eye, observing living cells in living eyes. We are located at the Quinze-Vingts Hospital in the center of Paris, and so we benefit from the medical environment of one of the largest eye hospitals in Europe. Our aim is to better understand eye diseases by combining conventional and cutting-edge approaches. We design and build many of the instruments we use, and the close interaction with ophthalmologists ensures that our research is medically pertinent. We conduct many research programs on retinal diseases, with patients from the Quinze-Vingts and from other collaborating hospitals. We mainly focus on age-related macular degeneration and diabetic retinopathy. Our findings have led to the adoption of novel diagnostic and therapeutic tools for treating eye diseases.

Site visitors